Article: Medical Science Systems Signs First International Agreement to Distribute Genetic Susceptibility Test.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Feb. 4, 1998--

The Company Expects International Sales to be a Growing Source

of Revenue

Medical Science Systems Inc. (Nasdaq:MSSI) Wednesday announced it has signed the first in a succession of expected international agreements to market and promote the company's first product, PST, the only genetic susceptibility test for periodontal disease.

The company expects this first international alliance, which is with Medicadent, to increase current-year revenues.

First Agreement

Medical Science Systems' president and chief executive officer, Paul J. White said, "The ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!